Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism

Clinical trial NCT00661141 · COMPLETED

Trial details

NCT number: NCT00661141
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aldehyde Dehydrogenase-2 (ALDH2) Deficiency

Start date: 2008-04-01
Primary completion: 2008-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.